SC 13G

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No.    )*

 

 

Absci Corporation

(Name of Issuer)

Common Stock, par value, $0.0001 per share

(Title of Class of Securities)

00091E109

(CUSIP Number)

December 31, 2021

(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

† ☐ Rule 13d-1(b)

† ☐ Rule 13d-1(c)

† ☒ Rule 13d-1(d)

 

*

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


CUSIP No. 00091E109

 

  1.   

Names of Reporting Persons:

 

Mark Valasek

  2.  

Check the Appropriate Box if a Member of a Group:

(a)  ☐        (b)  ☐

 

  3.  

SEC Use Only:

 

  4.  

Citizenship or Place of Organization:

 

United States

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

   5.    

Sole Voting Power:

 

5,535,334

   6.   

Shared Voting Power:

 

0

   7.   

Sole Dispositive Power:

 

5,535,334

   8.   

Shared Dispositive Power:

 

0

  9.   

Aggregate Amount Beneficially Owned by Each Reporting Person:

 

5,535,334(1)

10.  

Check if the Aggregate Amount in Row (9) Excludes Certain Shares

 

11.  

Percent of Class Represented by Amount in Row (9):

 

6.0%(1)

12.  

Type of Reporting Person:

 

IN

 

(1) 

Based on the quotient obtained by dividing (a) the aggregate amount beneficially owned by the Reporting Person as set forth in Row 9 by (b) 92,648,036 shares of common stock outstanding as of December 31, 2021.


CUSIP No. 00091E109

 

ITEM 1.

 

  (a)

Name of Issuer:

Absci Corporation

 

  (b)

Address of Issuer’s Principal Executive Offices:

18105 SE Mill Plain Boulevard

Vancouver, WA 98683

 

ITEM 2.

  (a)

Name of Person Filing:

Mark Valasek

 

  (b)

Address of Principal Business Office, or if None, Residence:

c/o Absci Corporation

18105 SE Mill Plain Boulevard

Vancouver, WA 98683

 

  (c)

Citizenship:

United States

 

  (d)

Title of Class of Securities:

Common stock, par value, $0.0001 per share

 

  (e)

CUSIP Number:

00091E109

ITEM  3.     IF THIS STATEMENT IS FILED PURSUANT TO SS.240.13d-1(b) OR 240.13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A:

 

(a)       Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o);
(b)       Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)       Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)       Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a—
      8);
(e)       An investment adviser in accordance with §240.13d—1(b)(1)(ii)(E);
(f)       An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
(g)       A parent holding company or control person in accordance with §240.13d—1(b)(1)(ii)(G);
(h)       A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)       A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the
      Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)       A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J)
(k)       Group, in accordance with §240.13d-1(b)(1)(ii)(J).

Not Applicable.

ITEM 4. OWNERSHIP.

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

 

  (a)

Amount beneficially owned: 5,535,334

 

  (b)

Percent of Class: 6.0%

 

  (c)

Number of shares as to which the person has:


(i) Sole power to vote or to direct the vote: 5,535,334

(ii) Shared power to vote or to direct the vote: 0

(iii) Sole power to dispose or to direct the disposition of: 5,535,334

(iv) Shared power to dispose or to direct the disposition of: 0

ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.

Not applicable.

ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.

Not applicable.

ITEM  7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.

Not applicable.

ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.

Not applicable.

ITEM 9. NOTICE OF DISSOLUTION OF GROUP.

Not applicable.

ITEM 10. CERTIFICATIONS.

Not applicable.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: February 14, 2022

 

Mark Valasek

/s/ Todd Bedrick, as Attorney-in-Fact for Mark Valasek


LIST OF EXHIBITS

 

Exhibit No.

  

Description

99.1    Power of Attorney
Exhibit 99.1

Exhibit 99.1

LIMITED POWER OF ATTORNEY

The undersigned hereby constitutes and appoints each of Gregory Schiffman, Sarah Korman and Todd Bedrick, signing singly, and with full power of substitution, the undersigned’s true and lawful attorney-in-fact to:

(1)    execute for and on behalf of the undersigned, in the undersigned’s capacity as stockholder of Absci Corporation (the “Company”), from time to time the following U.S. Securities and Exchange Commission (“SEC”) forms: (i) Form ID, including any attached documents, to effect the assignment of codes to the undersigned to be used in the transmission of information to the SEC using the EDGAR System; (ii) Schedules 13D and 13G and (iii) amendments of each thereof, in accordance with the Securities Exchange Act of 1934, as amended, and the rules thereunder, including any attached documents;

(2)    do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Schedules 13D and 13G or any amendment(s) thereto, and timely file such form(s) with the SEC and any securities exchange, national association or similar authority; and

(3)    take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.

The undersigned hereby grants to each such attorney-in-fact, acting singly, full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Regulation 13D-G of the Securities Exchange Act of 1934, as amended. The undersigned hereby agrees to indemnify the attorneys-in-fact and the Company from and against any demand, damage, loss, cost or expense arising from any false or misleading information provided by the undersigned to the attorneys-in-fact.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file such forms with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys- in-fact. This Power of Attorney supersedes any prior power of attorney in connection with the undersigned’s capacity as a stockholder of the Company. This Power of Attorney shall expire as to any individual attorney- in-fact if such attorney-in-fact ceases to be an employee of the Company.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of February 9th , 2022.

 

/s/ Mark Valasek

Mark Valasek